This basic science study demonstrates that BHQ and thapsigargin inhibit the sarcoplasmic reticulum Ca2+,Mg2+-ATPase by stabilizing the E2 conformation.
No takes yet. Share an insight, caveat, or question.
Should not change clinical practice; leaves open further preclinical evaluation of BHQ as a SERCA tool compound.
Wictome et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: